We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

By LabMedica International staff writers
Posted on 26 Aug 2025

About 37 million U. More...

S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient. Researchers have now developed a new approach that uses a simple breath sample to provide results in minutes, offering a fast and inexpensive method to identify both diabetes and prediabetes.

The innovation comes from Penn State (University Park, PA, USA), where scientists have designed a graphene-based breath sensor. The device detects acetone, a natural byproduct of fat metabolism, exhaled in breath. Everyone produces acetone, but levels above 1.8 parts per million indicate diabetes risk. Unlike earlier glucose sensors that required sweat or lab analysis, this method only needs a patient to exhale into a bag for quick on-site results.

The sensor was built using laser-induced graphene, a porous material created by burning polyimide film with a CO₂ laser. To improve selectivity, the researchers combined graphene with zinc oxide, forming a junction that made the sensor more effective at detecting acetone molecules. A special membrane was also added to block water vapor, which could otherwise interfere with readings.

Currently, patients must breathe into a bag to ensure accurate measurements without interference from environmental airflow. The study, published in Chemical Engineering Journal, confirmed the sensor could reliably detect acetone levels linked to diabetes and prediabetes. This proof-of-concept demonstrates a potential noninvasive alternative to blood-based diagnostics.

Going forward, the researchers aim to design a version of the sensor that works directly under the nose or inside a mask. They also see opportunities to expand its use, such as monitoring how acetone levels fluctuate with diet and exercise. Such insights could broaden the device’s applications beyond diabetes to general health tracking.

“While we have sensors that can detect glucose in sweat, these require exercise, chemicals, or a sauna, which are not always practical,” said Huanyu “Larry” Cheng, associate professor of engineering science and mechanics at Penn State. “This sensor only requires that you exhale into a bag, dip the sensor in, and wait a few minutes for results.”

Related Links:
Penn State


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Hematology Consumables
Bioblood Devices
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The platform analyzes cell-free DNA in blood, searching for minute amounts of tumor-derived fragments among background DNA (Image Credit: Adobe Stock)

Blood Test Could Help Fast-Track Lymphoma Diagnosis in Resource-Limited Settings

Lymphoma can be difficult to distinguish from infections and benign conditions, while definitive diagnosis often depends on surgical tissue sampling and specialized pathology that may not be readily available.... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.